Post-earnings recap
Reported
Thu, Feb 10, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Illumina's earnings report shows a solid performance on EPS, exceeding expectations by 50%. However, the stock fell 2.66% in reaction, likely due to the lack of revenue details and guidance. Investors may be cautious given the absence of forward-looking statements from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.75 | N/A | +50.00% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's long-term growth potential despite current market challenges. They noted the importance of continued innovation.
Management highlighted strong demand for genomic sequencing technology.
They emphasized ongoing investments in innovation and product development.